Showing results (111-120 of 220) with videos related to
Sort By:
Pageof 22
Movement Disorders : Official Journal of the Movement Disorder Society|September 26, 1997
A new tremor mutant in the Pietrain pig: an animal model of orthostatic tremor? Clinical and neurophysiological observationsJ Wissel, B Harlizuis, A Richter, et al.Clinical Neuropharmacology|February 1, 1988
Pharmacological study in Meige's syndrome with predominant blepharospasmG Ransmayr, B Kleedorfer, R A Dierckx, et al.Journal of Pain and Symptom Management|August 18, 2000
Management of spasticity associated pain with botulinum toxin AJ Wissel, J Müller, J Dressnandt, et al.Journal of Neurology|December 1, 1987
Visuoperception and visuospatial and visuorotational performance in Parkinson's diseaseG Ransmayr, B Schmidhuber-Eiler, E Karamat, et al.BMJ (Clinical Research Ed.)|October 26, 1996
Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study)S Kiechl, J Willeit, W Poewe, et al.Neurobiology of Disease|April 2, 2004
Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy)N Stefanova, M Lundblad, F Tison, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1994
Absence of disease related prion protein in neurodegenerative disorders presenting with Parkinson's syndromeK Jendroska, O Hoffmann, L Schelosky, et al.Lancet (London, England)|March 16, 2005
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trialO Rascol, D J Brooks, E Melamed, et al.European Journal of Neurology|October 25, 2018
Burden of non-motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa-carbidopa intestinal gelK Ray Chaudhuri, A Antonini, W Z Robieson, et al.European Journal of Nuclear Medicine|September 28, 2000
Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I-IBZME Donnemiller, C Brenneis, J Wissel, et al.Pageof 22